Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma
This study presents an accurate and reliable M2 macrophage-related risk model, enhancing understanding of distinct prognostic subsets in DLBCL. It offers potential novel drug options for future treatments.
Authors
- Hong Cen (ORCID: https://orcid.org/0000-0003-2232-9213)
- Ying Duan (ORCID: https://orcid.org/0009-0005-3288-9785)
- Baoping Guo (ORCID: https://orcid.org/0000-0002-2256-9885)
Institutions
- Guangxi Medical University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e41007
- Citations
- 3
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.27
Funders
- Natural Science Foundation of Guangxi Province
- Guangxi Zhuang Autonomous Region Health and Family Planning Commission